查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
泌尿道感染(UTI)治療的全球市場-成長，未來展望，競爭分析(2022年～2030年)
市場調查報告書
商品編碼
1192932

泌尿道感染(UTI)治療的全球市場-成長，未來展望，競爭分析(2022年～2030年)

Urinary Tract Infection (UTI) Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

本報告提供全球泌尿道感染(UTI)治療市場相關調查分析，市場動態，市場分析，企業簡介等系統性資訊。

目錄

第1章 序文

  • 報告的說明
    • 報告的目的
    • 目標受眾
    • 主要的產品
  • 市場區隔
  • 調查手法
    • 階段Ⅰ-2次調查
    • 階段Ⅱ-1次調查
    • 階段Ⅲ-專家的審查
    • 假設
    • 所採用的方法

第2章 摘要整理

  • 市場概述:全球泌尿道感染(UTI)治療市場
  • 全球泌尿道感染(UTI)治療市場(100萬美元)(2021年):各類藥物
  • 全球泌尿道感染(UTI)治療市場(100萬美元)(2021年):各地區
  • 富有魅力的投資提案(2021年):各地區

第3章 泌尿道感染(UTI)治療市場:競爭分析

  • 主要的泌尿道感染(UTI)治療市場供應商的市場定位
  • 泌尿道感染(UTI)治療市場供應商採用的策略
  • 主要的產業策略
  • 階層分析:2021年和2030年的比較

第4章 泌尿道感染(UTI)治療市場:常量分析和市場動態

  • 簡介
  • 全球泌尿道感染(UTI)治療市場金額(100萬美元)(2020年～2030年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • See-Saw分析

第5章 泌尿道感染(UTI)治療市場，美金(100萬)(2020年～2030年):各類藥物

  • 市場概要
  • 成長和收益分析::2021年和2030年的比較
  • 市場區隔
    • 青霉素
    • 奎諾酮
    • 頭孢菌素
    • 磺胺類藥物
    • 四環黴素
    • 其他

第6章 北美的泌尿道感染(UTI)治療市場，美金(100萬)(2020年～2030年)

第7章 英國及歐洲聯盟的泌尿道感染(UTI)治療市場，美金(100萬)(2020年～2030年)

第8章 亞太地區的泌尿道感染(UTI)治療市場，美金(100萬)(2020年～2030年)

第9章 南美的泌尿道感染(UTI)治療市場，美金(100萬)(2020年～2030年)

第10章 中東及非洲的泌尿道感染(UTI)治療市場，美金(100萬)(2020年～2030年)

第11章 企業簡介

  • AstraZeneca plc.
  • Bayer AG
  • Cubist Pharmaceuticals
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • Johnson & Johnson
  • MerLion Pharmaceuticals
  • Osel Inc.
  • Pfizer Inc.
  • Rempex Pharmaceuticals
Product Code: 137750-08-22

Urinary tract infection (UTI) is a most common type of infection, it involve infection to the kidneys, ureters, bladder, or urethra. UTI treatment market is rapidly growing due to factors such as growing prevalence of UTI, significant unmet needs, rising number of drug resistant bacteria due to excessive use of antibiotics.

The report titled "Urinary Tract Infection (UTI) Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022-2030" offers strategic insights into the overall UTI treatment market along with the market size and estimates for the duration 2020 to 2030. The research study covers in-depth analysis of market segments based on drug class (penicillin, quinolones, cephalosporin, sulphonamides, tetracycline and other) and different geographical regions.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global UTI treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global UTI treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global UTI treatment market. In-depth competitive environment analysis and historical years (2021) market size data are also provided in the report.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Urinary Tract Infection (UTI) Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Urinary Tract Infection (UTI) Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Drug Class

Penicillin

Quinolones

Cephalosporin

Sulphonamides

Tetracycline

Other

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Urinary Tract Infection (UTI) Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Urinary Tract Infection (UTI) Treatment market?

Which is the largest regional market for Urinary Tract Infection (UTI) Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Urinary Tract Infection (UTI) Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Urinary Tract Infection (UTI) Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Urinary Tract Infection (UTI) Treatment Market
  • 2.2. Global Urinary Tract Infection (UTI) Treatment Market, By Drug Class, 2021 (US$ Million)
  • 2.3. Global Urinary Tract Infection (UTI) Treatment Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Urinary Tract Infection (UTI) Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Urinary Tract Infection (UTI) Treatment Market Vendors
  • 3.2. Strategies Adopted by Urinary Tract Infection (UTI) Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Urinary Tract Infection (UTI) Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Urinary Tract Infection (UTI) Treatment Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Penicillin
    • 5.3.2. Quinolones
    • 5.3.3. Cephalosporin
    • 5.3.4. Sulphonamides
    • 5.3.5. Tetracycline
    • 5.3.6. Other

6. North America Urinary Tract Infection (UTI) Treatment Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
  • 6.3.Urinary Tract Infection (UTI) Treatment Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)

7. UK and European Union Urinary Tract Infection (UTI) Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
  • 7.3.Urinary Tract Infection (UTI) Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)

8. Asia Pacific Urinary Tract Infection (UTI) Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
  • 8.3.Urinary Tract Infection (UTI) Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)

9. Latin America Urinary Tract Infection (UTI) Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
  • 9.3.Urinary Tract Infection (UTI) Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)

10. Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
  • 10.3.Urinary Tract Infection (UTI) Treatment Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Urinary Tract Infection (UTI) Treatment Market: By Drug Class, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. AstraZeneca plc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Bayer AG
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Cubist Pharmaceuticals
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. F. Hoffmann-La Roche Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. GlaxoSmithKline Pharmaceuticals Ltd.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Johnson & Johnson
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. MerLion Pharmaceuticals
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Osel Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Pfizer Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Rempex Pharmaceuticals
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 2 North America Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 3 U.S. Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 4 Canada Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 5 Rest of North America Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 7 UK Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 8 Germany Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 9 Spain Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 10 Italy Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 11 France Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 12 Rest of Europe Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 13 Asia Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 14 China Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 15 Japan Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 16 India Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 17 Australia Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 18 South Korea Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 19 Latin America Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 20 Brazil Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 21 Mexico Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 22 Rest of Latin America Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 23 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 24 GCC Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 25 Africa Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 26 Rest of Middle East and Africa Urinary Tract Infection (UTI) Treatment Market By Drug Class, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Urinary Tract Infection (UTI) Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Urinary Tract Infection (UTI) Treatment Market: Quality Assurance
  • FIG. 5 Global Urinary Tract Infection (UTI) Treatment Market, By Drug Class, 2021
  • FIG. 6 Global Urinary Tract Infection (UTI) Treatment Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Urinary Tract Infection (UTI) Treatment Market, 2021
  • FIG. 8 Market Positioning of Key Urinary Tract Infection (UTI) Treatment Market Players, 2021
  • FIG. 9 Global Urinary Tract Infection (UTI) Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Urinary Tract Infection (UTI) Treatment Market, By Drug Class, 2021 Vs 2030, %
  • FIG. 11 U.S. Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 France Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 China Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 India Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Urinary Tract Infection (UTI) Treatment Market (US$ Million), 2020 - 2030